Spontaneous subdural hematoma and antiplatelet therapy: Does efficacy of Ticagrelor come with added risk?

Spontaneous subdural hematoma and antiplatelet therapy: Does efficacy of Ticagrelor come with added risk?

Antiplatelet therapy has established clinical benefit on cardiovascular outcome and has reduced the rates of re-infarction/in stent thrombosis following percutaneous coronary intervention in acute coronary syndromes. Major bleeding episodes can occur with antiplatelet therapy and intracranial hemorr...

Full description

Bibliographic Details
Main Authors: Pattanagere Manjunatha Suryanarayana Sharma, Aniruddha Tekkatte Jagannatha, Mahendra Javali, Anupama Venkatasubba Hegde, Rohan Mahale, Madhusudhan, Rangasetty Srinivasa
Format: Article
Language:English
Published: Elsevier 2015-12-01
Series:Indian Heart Journal
Subjects:
Antiplatelet therapy
Ticagrelor
Intracranial hemorrhage
Subdural hematoma
Acute coronary syndrome
Online Access:http://www.sciencedirect.com/science/article/pii/S0019483215002503

Internet

http://www.sciencedirect.com/science/article/pii/S0019483215002503

Similar Items